The poly(rC)-binding proteins (PCBP1 and PCBP2) are RNA-binding proteins whose RNA recognition motifs are composed of three K homology (KH) domains. These proteins are involved in both the stabilization and translational regulation of several cellular and viral RNAs. PCBP1 and PCBP2 specifically interact with both the 5-element known as the cloverleaf structure and the large stem-loop IV RNA of the poliovirus 5-untranslated region. We have found that the first KH domain of PCBP2 (KH1) specifically interacts with the viral RNAs, and together with viral protein 3CD, KH1 forms a high affinity ternary ribonucleoprotein complex with the cloverleaf RNA, resembling the full-length PCBP protein. Furthermore, KH1 acts as a dominant-negative mutant to inhibit translation from a poliovirus reporter gene in both Xenopus laevis oocytes and HeLa cell in vitro translation extracts.
Translation in eukaryotic cells is a highly regulated process involving a complex protein machinery. There is increasing evidence that translation of several mRNAs is determined by the specific and regulated interaction of certain proteins with RNA elements in the 3Ј-and 5Ј-untranslated regions (for reviews, see Refs. 1 and 2). Although many of these cis-acting RNA elements have been defined, only a few trans-acting regulatory proteins are known, and the mechanisms by which they regulate translation are poorly understood.
As with cellular messages, translation of viral RNA is also subjected to complex regulation. For example, for positive strand RNA viruses, the genomic RNA is utilized as a template for translation, RNA replication, and formation of new virions; hence, the usage of the RNA must be regulated. For poliovirus, this regulation seems to be dependent on signals within the 5Ј-UTR. 1 Whereas the majority of cellular mRNAs depend on the 5Ј-cap structure to initiate translation, poliovirus initiates translation internally via a cap-independent mechanism from an RNA element termed the internal ribosomal entry site (IRES) located within the 5Ј-UTR. Computer modeling and biochemical analysis suggest that the secondary structure of the poliovirus 5Ј-UTR is composed of six distinct domains, stem-loops I-VI (see Fig. 1A ). In addition to the canonical initiation factors, poliovirus translation initiation requires additional host cell factors, some of which appear to interact directly with the viral RNA (reviewed in Refs. 3 and 4) . Among these essential factors are PCBP1 and PCBP2, two closely related poly(rC)-binding proteins, (also referred to as hnRNPs E1 and 2 or ␣CP1 and ␣CP2). These proteins facilitate viral translation through the interaction with both the first stemloop domain (which folds into a cloverleaf-like structure) and stem-loop IV of the poliovirus 5Ј-UTR (5) (6) (7) (8) . Both PCBP1 and PCBP2 form a low affinity complex with the cloverleaf RNA, but together with viral protein 3CD (the precursor of the viral polymerase 3D and the viral protease 3C), they are incorporated into a high affinity ternary ribonucleoprotein complex (9, 10) . Ternary complex formation is required for positive strand RNA synthesis (9) . Moreover, the interactions of the PCBPs and 3CD with the cloverleaf RNA seem to determine whether the genomic RNA is used as a template for protein synthesis or RNA replication. Binding of PCBPs to the cloverleaf stimulates viral translation, whereas binding of 3CD down-regulates translation (11) .
Recent evidence indicates that association of PCBPs with a number of cellular mRNAs is important for their post-transcriptional regulation, either by stabilizing or by directly influencing the translational state of the mRNA (reviewed in Ref. 12) . For instance, PCBPs interact with the highly stable 15-lipoxygenase mRNA (13) , inducing translational silencing presumably by inhibition of 80 S ribosome assembly (14) . In addition to their role in poliovirus translation, PCBPs have been implicated in the regulation of translation of other viral RNAs. Depletion of PCBPs from in vitro translation extracts leads to a reduction of protein synthesis from hepatitis A virus (15) ; and addition of PCBP1, PCBP2, and hnRNP K to in vitro translation reactions induces translational silencing of the human papilloma virus type 16 L2 mRNA (16) .
PCBP1 and PCBP2 contain three copies of the RNA-binding K homologous (KH) motif, first described for hnRNP K (17) . The arrangement of these three motifs within hnRNP K, PCBP1, and PCBP2 is similar: two consecutive KH domains at the amino terminus followed by a region of variable sequence and length preceding a third KH motif. The degree of homology within the corresponding domain in all of these proteins is higher than that shared by KH motifs within the same polypeptide (18) . No other known RNA-binding motif is found within the PCBPs, and the KH domains are able to function as discreet and independent nucleic acid-binding units: expression of each of the three domains individually demonstrated that the KH1 and KH3 domains of PCBP1 and PCBP2 specifically bind to poly(rC) homopolymers (19) . However, the basis for the association of these KH domain-containing proteins with their specific RNA targets, such as the cloverleaf and stem-loop IV of the poliovirus 5Ј-UTR, remains to be established.
We have examined the determinants for poliovirus RNA recognition in PCBP. By expression of individual KH domains, we have found that KH1, the first KH motif of PCBP, is able to specifically recognize both the cloverleaf and stem-loop IV structures of the poliovirus 5Ј-UTR. In addition, the KH1 domain retains the ability to form a high affinity ternary complex with the cloverleaf and viral protein 3CD. Finally, we show that the KH1 protein specifically inhibits translation from a poliovirus IRES and not from a capped mRNA and that this effect appears to be mediated by a direct competition of KH1 with endogenous PCBPs for the binding sites within the poliovirus 5Ј-UTR.
EXPERIMENTAL PROCEDURES
Expression of Recombinant Proteins-KH domain sequences were amplified from a plasmid containing PCBP sequences, pMAL-PCBP (6). Primers contained restriction digest sites to facilitate their insertion into the pMAL-c2 vector (New England Biolabs Inc.). KH1 was amplified using oligonucleotides 1 (GCTAGCGAATTCGACACCGGTGTGAT-TGAA) and 2 (TAGCAGGGATCCCTACCTCAGGGTGACCGG). KH2 was amplified using oligonucleotides 3 (GCTAGCGAATTCCCGGTCA-CCCTGAGG) and 4 (TAGCAGGGATCCCTAGGACTGGGAGAGAGT). For amplification of the KH3 domain, oligonucleotides 5 (GCTAGCGA-ATTCGGTTTGGATGCATCT) and 6 (TAGCAGGGATCCCTAGCTGCT-CCCCATGCC) were used. All resulting polymerase chain reaction fragments were digested with BamHI and EcoRI and ligated into the pMAL vector digested with the same enzymes. Recombinant MBP fusion proteins were produced and purified by affinity chromatography using an amylose resin (New England Biolabs Inc.) as recommended by the manufacturer. The resulting protein preparations were 85-95% pure, and protein concentrations were determined by Coomassie Blue staining of SDS-polyacrylamide gels.
Mutagenesis of Recombinant Proteins-Single-stranded uracil-containing pMAL-PCBP DNA was generated by standard methods (20) . This DNA was then used as a template to generate site-directed mutants in each of the KH domains of the protein. Oligonucleotides 7 (GAAGTTGGCAGTATCGCCGCAAAGAAAGCAGAATCAGTTAAGAA-GATG), 8 (CAGTGTGGCTCTCTCGCTGCAAAAGGTGCATGCAAGAT-CAAGGAAATA), and 9 (TTGATTGGCTGCATAGCCGCGCGTCAAGC-CGCCAAAATCAATGAGATC) were used to generate mutations in the KH1, KH2, and KH3 domains, respectively. Mutant KH1 fragment was generated by amplification from the mutant in the complete PCBP protein using oligonucleotides 1 and 2, digestion with BamHI and EcoRI, and ligation into the pMAL vector digested with the same enzymes. The presence of the mutations was confirmed by restriction digest analysis followed by DNA sequencing. The resulting proteins were expressed and purified as described above.
RNA Binding Assays-RNA binding reactions and electrophoretic mobility shift assays were performed as described (6) . Briefly, probes were uniformly labeled by incorporation of [␣- 32 P]UTP during in vitro T7 polymerase transcription. Cloverleaf and stem-loop IV probes consisted of nucleotides 1-108 and 234 -459 of the poliovirus genome, respectively. The binding reactions contained 5 mM HEPES, pH 7.9, 40 mM KCl, 2 mM MgCl 2 , 4% glycerol, 2 mM dithiothreitol, 3 ng of uniformly labeled [
32 P]RNA (35,000 cpm), 5 mg/ml brewers' yeast tRNA (cloverleaf reactions) or 1 mg/ml brewers' yeast tRNA and 0.25 mg/ml heparin (stem-loop IV reactions), and HeLa cell extract or recombinant proteins in a final volume of 20 l. Reactions were incubated for 10 min and loaded onto nondenaturing polyacrylamide gels (5% for cloverleaf and 4% for stem-loop IV) containing 5% glycerol. Unlabeled competitor RNAs and antibodies were added as described for each experiment. Binding constants were calculated after quantification of the resulting complexes in a PhosphorImager (Molecular Dynamics, Inc.) using a least-squares fit analysis. For recombinant proteins that were unable to reach at least 50% shift of RNA probe into a complex, the binding affinity was estimated visually by extrapolation of the resulting curve.
Microinjections into Xenopus Oocytes-Oocytes were surgically isolated (21) and enzymatically defolliculated by treatment with 2 mg/ml collagenase (Worthington) for 3 h at room temperature with gentle shaking. Defolliculated oocytes were washed with modified Barth's solution (7.5 mM Tris, pH 7.6, 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 8.2 mM MgSO 4 , 100 units/ml penicillin, 100 mg/ml streptomycin, and 2% Ficoll 400). Stage VI oocytes were manually sorted and injected with 20 nl of in vitro transcribed Polio-Luc RNA (1 g/l), 20 nl of depleted or mock-treated HeLa S10 extract, and 20 nl of recombinant KH1 protein (2.5 g/l). Twenty oocytes were lysed in 200 l of lysis buffer (Promega) at the indicated times and spun for 5 min at 10,000 ϫ g. Ten microliters of supernatant were assayed for luciferase activity using an Optocomp I luminometer and the Promega luciferase assay reagent. To compare between experiments using either depleted or mock-depleted HeLa cell extracts, injected and control (no RNA injected) oocytes were incubated in the presence of 400 Ci/ml [ 35 S]methionine. At the indicated time points, 10 l of extract were subjected to trichloroacetic acid precipitation (20) to calculate total incorporation of label. The incorporation into control oocytes was set at an arbitrary value of 1 and used to normalize the values of incorporation into viral RNA-injected oocytes. The relative light units of each individual injection as measured in the luminometer were divided by the values obtained by normalization of label incorporation. The variation in the amount of label incorporated was not significant.
HeLa Cell Extract Preparation-HeLa S3 cells were grown in suspension in Joklik's minimal essential medium supplemented with 10% newborn calf serum. Cytoplasmic extract (S10) was prepared from 2 liters of HeLa cells. Cells were harvested by centrifugation, washed three times with cold phosphate-buffered saline, resuspended in 1.5 volumes of hypotonic buffer (20 mM HEPES, pH 7.4, 10 mM KCl, 1.5 mM MgAc 2 , and 2 mM dithiothreitol), incubated on ice for 2 min, and broken by Dounce homogenization. A post-nuclear supernatant was obtained by centrifugation at 5000 ϫ g for 10 min at 4°C, and S10 cytoplasmic extract was obtained by further centrifugation of the supernatant at 10,000 ϫ g for 15 min. The resulting extract was supplemented with 5% glycerol and stored at Ϫ80°C. HeLa cell in vitro translation extracts were prepared in the same manner, except that after the 15,000 ϫ g centrifugation step, the extract was adjusted to 1 mM CaCl 2 and treated with 75 units/ml Staphylococcus aureus nuclease for 15 min at room temperature. The nuclease was inactivated by addition of 2 mM EGTA. The extract was supplemented with 10% glycerol before storage at Ϫ80°C. To deplete PCBPs from HeLa S10 extract, the extract was incubated with biotinylated stem-loop IV RNA immobilized with streptavidin beads as described (6) . Briefly, 50 g of biotinylated stemloop IV RNA were incubated with 25 l of streptavidin beads (Pierce) on ice for 30 min and washed five times with hypotonic buffer. The RNAbead complex was then incubated with 100 l of HeLa S10 extract for 1 h on ice, spun at 15,000 ϫ g for 5 min, and used for microinjection. For mock-depleted extracts, HeLa S10 extract was incubated with streptavidin beads alone. Efficiency of depletion was measured by Western blot analysis with antibodies that specifically recognize either PCBP1 or PCBP2.
In Vitro Translation Reactions-Translation reactions were carried out as described (22) . Briefly, 20 -30-l reactions consisted of 50% HeLa translation extracts, 1 mM ATP, 0.2 mM GTP, 120 mM KAcO, 2.75 mM MgAcO, 3 mM dithiothreitol, 35 mM HEPES, pH 7.4, 25 mM creatine phosphate, 400 g/ml creatine-phosphate kinase, 0.2 mM spermidine, 20 M amino acids, 400 units/ml RNase inhibitor, 0.5-1 g/l RNA (Polio-Luc or Cap-Luc), and the indicated amounts of recombinant KH proteins. Translation reactions were incubated at 32°C for the indicated times and assayed directly for luciferase activity using an Optocomp I luminometer and the Promega luciferase assay substrate.
RESULTS

The KH1 Domain of PCBP Binds to Both the Cloverleaf
Structure and Stem-loop IV of the Poliovirus 5Ј-UTR-To determine whether subdomains of PCBPs are able to specifically interact with target RNAs within the poliovirus 5Ј-UTR (Fig.  1A) , we expressed in Escherichia coli each of the individual KH domains as fusions to MBP. The boundaries for each KH domain (Fig. 1B) were identical to those previously described (19) . Purified recombinant proteins (KH1, KH2, and KH3) were used for binding reactions with radiolabeled RNA probes. The initial results indicated that the corresponding domains from PCBP1 and PCBP2 interact with the RNA probes in a similar fashion; therefore, subsequent experiments were performed using the PCBP2-derived fragments. The three recombinant proteins behaved as described previously (19) : in filter binding assays, both KH1 and KH3 bound to radiolabeled poly(rC), but not to poly(rA) RNA, whereas the KH2 domain did not interact with either RNA (data not shown).
We then determined the ability of each KH domain to inter-act with the specific RNA targets of PCBPs within the poliovirus 5Ј-UTR. Electrophoretic mobility shift assays revealed that the KH1 domain interacted with both the stem-loop IV and cloverleaf RNAs (Fig. 1 , C, lanes 1-3 for stem-loop IV; and D, lanes 2-5 for the cloverleaf). In contrast, the KH2 and KH3 domains did not form complexes with either of the probes (Fig.  1 , C, lanes 4 -9 for stem-loop IV; and D, lanes 6 -13 for the cloverleaf). More important, both the KH1-MBP fusion protein and the isolated KH1 domain bound to the stem-loop IV and cloverleaf RNAs with similar affinities (Fig. 1 , C, lanes 11 and 12; and D, lanes 14 and 15) and behaved similarly in functional experiments (data not shown). However, because the solubility and stability of the fusion proteins were higher than for the isolated KH domains, we employed the fusion proteins throughout the rest of this study.
To determine whether the interaction of KH1 with the cloverleaf RNA was sequence-specific, we performed competition experiments using unlabeled RNA. The complex formed by the KH1 protein and the cloverleaf RNA was competed by unlabeled cloverleaf RNA in a dose-dependent manner, but was not affected by a nonspecific RNA competitor (Fig. 1E, compare  lanes 2-4 with lanes 5-7) . Similar results were obtained in competition experiments with a stem-loop IV RNA probe (data not shown).
Taken together, these results suggest that the KH1 domain is the major determinant for recognition of the specific RNA targets of PCBP within the poliovirus 5Ј-UTR. In contrast, the other two domains (KH2 and KH3) are not able to form stable ribonucleoprotein complexes under any of the conditions tested.
The KH1 Domain of PCBP Forms a High Affinity Complex with the Cloverleaf RNA and Viral Protein 3CD-Interactions between the cloverleaf, PCBPs, and 3CD are involved in the regulation of both viral translation and RNA synthesis. Experiments demonstrated that the PCBPs specifically interacted with stem-loop B of the poliovirus cloverleaf structure, whereas viral protein 3CD contacted the RNA near unpaired nucleotides at the top of stem-loop D (Fig. 2A) . As previously described, the cloverleaf RNA formed a low affinity complex with PCBP (RNP-A) (Fig. 2B ) or with 3CD (RNP-b) (Fig. 2B, lane 3) . However, PCBP and 3CD together formed a very stable ternary ribonucleoprotein complex with the cloverleaf RNA (RNP-B) (Fig. 2B, lane 4) (9, 10) .
Because the KH1 protein binds to the cloverleaf RNA by itself, we determined whether this single domain is able to participate in the formation of the ternary complex. In the absence of 3CD, the KH1 domain fused to MBP formed a complex with slower mobility than that formed by PCBPs obtained from HeLa cells (RNP-AЈ) (Fig. 2C, lane 1) . Upon addition of 3CD, the RNP-AЈ complex was further retarded to form RNP-BЈ (Fig. 2C, lane 5) . Addition of antibodies directed against PCBP2 or 3D resulted in a supershift of the RNP-BЈ complex, confirming that this complex includes both 3CD and the KH1 protein (Fig. 2C, lanes 6 and 7) . The antibodies directed against 3D reacted only with the complexes formed by 3CD, and not those formed by the KH1 protein (Fig. 2C, compare lanes 2, 6, and 10) . Similarly, antibodies directed against PCBP2 slowed the migration of both the ternary complex and RNP-AЈ, formed by the KH1 protein, but not of RNP-b, formed by 3CD alone (Fig. 2C, compare lanes 3, 7, and 11) .
The formation of the ternary complex composed of 3CD, PCBP, and the cloverleaf RNA is cooperative (10) . To investigate whether the interaction of KH1 with the ternary complex is cooperative as well, we performed binding experiments by adding increasing amounts of KH1 protein to the cloverleaf RNA in the presence or absence of a constant concentration of 3CD. Both the complex formed by the RNA and KH1 (RNP-AЈ) and that consisting of 3CD and the cloverleaf (RNP-b) were efficiently converted into the ternary complex (RNP-BЈ), and the amount of free probe was greatly reduced in the reactions in which all three components were present (Fig. 2D) , suggesting that the isolated KH1 domain interacts with 3CD and the cloverleaf in a cooperative manner. To confirm this observation, we determined the binding affinities of the KH1 domain for the cloverleaf in the presence or absence of a constant amount of recombinant 3CD. In the case of the complex formed by recombinant KH1 and the cloverleaf, the apparent K d was calculated to be Ͼ100 M. In contrast, in the presence of 3CD, KH1 bound with high affinity to the cloverleaf RNA, resulting in a dissociation constant of 1.3 M (Fig. 3A) . Thus, the affinity of the KH1 domain for the cloverleaf RNA was ϳ90-fold higher in the presence of 3CD. For full-length recombinant PCBP2, the apparent K d for the cloverleaf RNA structure was 20 M in the absence of 3CD and 0.10 M in its presence (Fig. 3B) , resulting in Ͼ200-fold decrease in the dissociation constant for this protein. The affinity of viral protein 3CD for the cloverleaf RNA increased when the KH1 domain was added to the reaction, from an apparent K d of 550 nM in the absence of KH1 to 28 nM in its presence. Therefore, 3CD and the KH1 domain bind to the cloverleaf RNA cooperatively to form the ternary ribonucleoprotein complex.
Effect of the Mutation of a Highly Conserved Amino Acid Sequence within the KH Domains of PCBP on Poliovirus RNA
Binding-The KH motif, found in a variety of RNA-binding proteins, is composed of ϳ70 amino acids (23) . The NMR structures of the sixth KH domain of vigillin (23) and of the first KH motif from FMR-1 (24) as well as the crystal structure of the third KH domains of the proteins Nova-1 and Nova-2 have been obtained (25) . These structural data, coupled with mutational analysis, suggest that a highly conserved tetrapeptide motif (Gly-X-X-Gly) directly contacts the RNA target (24) . This tetrapeptide forms part of a flexible loop in the structure and often contains positively charged amino acids at the X positions. Replacement of the first Gly of this motif in the KH domain of the GLD-1 protein from Caenorhabditis elegans abolishes binding to its cognate RNA (26) and leads to a loss-of-function phenotype (27) . Moreover, site-directed mutagenesis of this motif (substitution of Ile-Gly-X-X-Gly for Ala-Ala-X-X-Ala) in the KH domains of hnRNP K abolishes its ability to bind poly(rC) (28) . Based on these observations, we substituted three conserved residues with alanines in the recombinant KH1 protein (I 29 GKKG to A 29 AKKA, mutant KH1 29 ). Mobility shift analysis revealed that these mutations completely abolished the ability of the protein to bind to either the cloverleaf (Fig. 4A) or stem-loop IV (data not shown) RNA structures.
To test the effect of these mutations in the context of fulllength PCBP2, we introduced similar mutations into each KH domain of full-length PCBP2 by site-directed mutagenesis (I 29 the complexes formed by the wild-type recombinant protein (Fig. 4B, compare lanes 2-4 with lanes 8 -13 and lanes 15-17  with lanes 21-26) . Second, quantification of the ratio of RNA bound versus the total radioactivity revealed that the binding affinities of the mutant proteins for the viral RNAs are significantly lower than those of wild-type PCBP2 (Fig. 5) . The most profound effects on binding were observed for the mutant in the KH1 domain, PCBP 29 , which only formed detectable complexes with the poliovirus RNAs at the highest concentrations of protein tested (Fig. 4B, lanes 5 and 18) . Interestingly, PCBP 29 binding to the cloverleaf RNA was facilitated by the presence of 3CD, but only to a limited extent. Whereas the affinity of wild-type PCBP2 increased by Ͼ200-fold in the presence of 3CD (see Fig. 3A ), the binding of PCBP 29 was only five times higher when the viral protein was included in the reaction. PCBP2 mutated in the KH3 domain (PCBP 303 ) bound with slightly better affinities than PCBP 29 to both the cloverleaf (Fig. 5A ) and stem-loop IV (Fig. 5C ) RNAs. However, it formed weak complexes with considerably low affinities when compared with wild-type PCBP2. In the presence of 3CD, the affinity of PCBP 303 for the cloverleaf RNA dramatically increased (by Ͼ100-fold). Finally, the protein containing a mutation in the second KH domain (PCBP 113 ) bound to the poliovirus RNA structures more efficiently than any of the other mutant proteins. Although PCBP 113 interacted with lower affinities that the wild-type protein with both stem-loop IV and the ternary complex, it bound to the cloverleaf RNA with kinetics similar to those of wild-type PCBP2 (Fig. 5A, compare  closed circles with open squares) .
Thus, although amino acid alterations within the KH1 domain of PCBP2 exhibited the most profound reduction of RNA binding activity (Figs. 4 and 5) , mutation of the other two KH domains in full-length PCBP2 also affected complex formation. These results suggest that even though the KH1 domain is the major determinant for poliovirus RNA binding by PCBP2, the other two domains play an important role in stabilizing the interactions with these RNAs.
The KH1 Domain Inhibits Translation from a Poliovirus IRES-PCBPs are essential factors for poliovirus IRES-mediated translation (6 -8) . We reasoned that since the KH1 domain can interact with the viral RNA, it might be able to compete for binding to the poliovirus RNA with the endogenous PCBPs and act as a dominant-negative mutant to interfere with viral translation. To examine this possibility, we microin- jected recombinant KH proteins into Xenopus oocytes together with a poliovirus replicon in which the structural genes were replaced by the luciferase gene (Polio-Luc) (Fig. 6A) (10) . Since translation from a poliovirus IRES in oocytes requires additional HeLa cell factors (29) , injections included a HeLa cell cytoplasmic fraction. Translation was measured directly as a function of luciferase activity (10) . Co-injection of KH1 and the Polio-Luc RNA led to a 5-30-fold inhibition of translation (Fig.  6B) . Furthermore, KH1 inhibited poliovirus translation by 50 -125-fold when a PCBP-depleted HeLa cell extract was co-injected instead of the complete HeLa S10 extract (Fig. 6C) . This result suggests that the inhibitory effect of KH1 is reduced by the presence of endogenous PCBPs and that the KH1 domain competes with these proteins for the RNA target within the poliovirus 5Ј-UTR. Consistent with this conclusion, two KH domains (KH3 and KH1 29 ) that do not interact in vitro with either the cloverleaf or stem-loop IV RNA did not inhibit translation (Fig. 6D) .
We also tested the inhibitory activity of the KH1 protein in a HeLa cell-free translation system. As in the oocytes, poliovirus IRES-directed protein synthesis was reduced upon addition of recombinant KH1 (Fig. 7A) , and the degree of inhibition depended on the amount of recombinant KH1 added to the reaction. In contrast, addition of a control KH1 29 mutant (which does not bind the RNA) (Fig. 4A) did not significantly affect translation of Polio-Luc (Fig. 7, A and B) . Furthermore, the inhibition by KH1 was specific for IRES-dependent protein synthesis because translation of a capped luciferase mRNA (Cap-Luc) was not significantly affected by the presence of KH1 during the reaction (Fig. 7B) . Taken together, these results indicate that the KH1 fragment acts as a dominant-negative mutant, specifically inhibiting poliovirus translation through an interaction with the viral RNA.
DISCUSSION
Role of KH Domains in PCBP Binding to the Poliovirus 5Ј-UTR-We have mapped the determinants for PCBP2 binding to two RNA structures of the poliovirus 5Ј-UTR, the cloverleaf and stem-loop IV. Although both the KH1 and KH3 domains bind to poly(rC) homopolymers (Ref. 19 and data not shown), only KH1 was capable of specifically interacting with the poliovirus RNA structures. In addition, mutation of KH1 within PCBP2 led to the most dramatic defects in RNA binding. These results suggest that the KH1 domain is the major RNAbinding determinant for the recognition of the poliovirus-specific RNA targets by PCBPs. However, the KH2 and KH3 domains must play an important role in these interactions because mutations in these domains have a detrimental effect on the binding by the full-length protein and alter complex migration as well (see Figs. 4B and 5). It is possible that mutations in the KH2 and KH3 domains of full-length PCBP alter the entire structure or induce misfolding of the protein in E. coli. However, this possibility seems unlikely because expression levels of the mutant proteins as well as their stability and solubility are comparable to those of wild-type PCBP2 (data not shown). Furthermore, we introduced these mutations into a flexible loop of the KH domain structure (23, 24) , and sequence changes in this site are not expected to have a major effect on the overall structure of the protein. Similar results were previously obtained for the binding of hnRNP K to poly(rC) RNA. Mutation of any of the three KH domains of this protein abolishes RNA binding (28) , but only the KH3 fragment interacts with poly(rC) RNA (19) . We do not know how KH2 and KH3 stabilize the interaction of PCBP2 with the viral RNA, but because individual domains do not enhance the RNA binding ability of each other when combined in mobility shift experiments (data not shown), it appears that all three motifs must be tethered within a single polypeptide to have optimal affinity for the RNA.
How Does KH1 Facilitate High Affinity Ternary Complex Formation?-The isolated KH1 domain stimulates the formation of the high affinity ternary complex (RNP-BЈ), which includes the cloverleaf RNA and 3CD (Fig. 3) . There are at least two possible mechanisms by which KH1 can facilitate the formation of this complex. First, binding of KH1 may trigger a conformational change in the cloverleaf RNA to render a target structure that interacts better with 3CD. Second, protein-protein interactions between KH1 and 3CD could stabilize the complex. Since the small KH1 domain can promote ternary complex formation by itself, it is likely that the binding of KH1 to stem-loop B of the cloverleaf RNA (see Fig. 2A ) alters the structure of this RNA to favor 3CD binding. It is also possible that the KH1 portion of PCBP2 could contain both an RNAbinding domain and a 3CD recognition surface. However, we have not been able to observe a direct protein-protein interaction between PCBP2 or KH1 and 3CD (data not shown). However, a protein-protein interaction of KH1 with 3CD might occur only through a conformational change of the KH1 fragment upon binding to the RNA. This would be consistent with the observation that the KH1 mutant does not affect the interaction of 3CD with the cloverleaf RNA (see Fig. 4A, lanes 5 and   FIG. 7 . The KH1 domain of PCBP inhibits translation in a HeLa cell-free translation extract. A, shown is the dose-response curve of inhibition by the KH1 fragment. HeLa cell in vitro translation reactions were carried out in the presence of the indicated amounts of wild-type (closed diamonds) and mutant (open circles) recombinant KH1 proteins. Luciferase activity is given as relative units (RU) normalized as a fraction of the translation activity in the absence of recombinant KH proteins (representing 1 relative unit) . B, HeLa cell in vitro translation extracts were programmed with 1 g of Polio-Luc (left bars) and Cap-Luc (right bars) RNAs. Translation reactions were carried out in the presence of 5 M wild-type (white bars) and mutant (black bars) recombinant KH1 proteins. Luciferase activity was measured after 1 h of incubation at 32°C. Results are expressed as the percent activity of a buffer control (which represents 100%) and are the average of three independent experiments. 6). At this point, we cannot definitively exclude any of these possible mechanisms, and further work will be necessary to establish how the PCBPs and KH1 enhance RNP-B complex formation.
The KH1 Domain Is a Competitive Inhibitor of PCBP Function in Viral Translation-The isolated KH1 domain is able to inhibit translation from a poliovirus IRES. This result adds to the growing body of evidence that supports the notion that PCBPs are an essential component of the poliovirus translation process. Mutations that abolish PCBP binding in either the cloverleaf (7, 11) or stem-loop IV (5) RNA structure impair viral translation. Moreover, depletion of PCBPs either from HeLa cell translation extracts (by RNA affinity methods) or from oocytes (by co-injection of antibodies or decoy RNAs) leads to a decrease in translation (6, 8, 11) .
The molecular details of the activation of viral translation by the PCBPs are not yet understood. PCBPs could be acting as a molecular bridge interacting with both canonical and non-canonical factors implicated in IRES-mediated initiation of translation, or alternatively, PCBPs could be inducing a conformational change in the poliovirus IRES necessary for the recognition of the RNA by these factors. In the absence of more precise information about the mechanism of activation by PCBP, it is difficult to understand how the KH1 fragment inhibits translation. Our data indicate that the inhibitor must be acting by directly competing with endogenous PCBPs for the RNA target because (i) the amount of PCBPs present during the translation reaction inversely correlates with the extent of inhibition, and (ii) a KH1 mutant that does not interact with the RNA did not have an effect on poliovirus translation (see Fig. 7 ). The KH1 protein appears to lack important determinants for either protein-protein interactions with the translational machinery or additional RNA-binding sites required to exert a conformational change in the IRES. Mutant PCBPs that do not bind to the RNA might be also able to interfere with poliovirus translation. Characterization of such mutants as well as examination of the effect of KH1 on the assembly of functional translation initiation are important and will be the focus of future investigation. Since the KH1 fragment is able to inhibit translation in a HeLa cell extract, which contains a high amount of endogenous PCBPs, this dominant-negative protein is a valuable tool that can be utilized to dissect the role of PCBP1 and PCBP2 in viral translation and replication, both in vitro and in intact cells.
